74 results
Page 3 of 4
8-K
EX-10.3
ahmm qhc3
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
DEFM14A
19azre
6 Nov 18
Proxy related to merger
12:00am
424B3
eq7k11jxjm5nrbkk j8
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
EX-10.46
i67s senm7
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
nkgq3r5
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-10.2
ne07nyx0
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-10.2
6jlb9kk gn9oo3
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-3.1
3b66wrudhxu9f yvkrh
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-3.1
keqr8 2tepb86g4m
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-3.1
il4xz2x ipdpkxq1lw
23 Dec 16
OvaScience Announces Business Update
12:00am
8-K
EX-1.1
dyxke zpepoxa73e
8 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
j7wkuskz
6 Mar 14
Entry into a Material Definitive Agreement
12:00am